Search results for: Keith Wille

Items from 1 to 13 out of 13 results

article

Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID‐19 cohort

Neel Shah, Bing Xue, Ziqi Xu, Hanqing Yang, more

Artificial Organs > 47 > 9 > 1490 - 1502

Background Veno‐venous extracorporeal membrane oxygenation (V‐V ECMO) is a lifesaving support modality for severe respiratory failure, but its resource‐intensive nature led to significant controversy surrounding its use during the COVID‐19 pandemic. We report the performance of several ECMO mortality prediction and severity of illness scores at discriminating survival in a large COVID‐19 V‐V ECMO...

article

State of the art – Extracorporeal membrane oxygenation as a bridge to thoracic transplantation

Erik Orozco‐Hernandez, Thomas Kurt DeLay, Enrique Gongora, Chris Bellot, more

Clinical Transplantation > 37 > 2 > n/a - n/a

Background Extracorporeal membrane oxygenation (ECMO) has revolutionized the treatment of refractory cardiac and respiratory failure, and its use continues to increase, particularly in adults. However, ECMO‐related morbidity and mortality remain high. Main Text In this review, we investigate and expand upon the current state of the art in thoracic transplant and extracorporeal life support (ELS)...

article

Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction

The EPI Study Group, Chadi A. Hage, Julia Klesney‐Tait, Keith Wille, more

Transfusion Medicine > 31 > 4 > 292 - 302

Background This study was designed to prospectively evaluate the efficacy of extracorporeal photopheresis (ECP) to attenuate the rate of decline of FEV₁ in lung transplant recipients with refractory bronchiolitis obliterans. Due to an observed higher than expected early mortality, a preliminary analysis was performed. Study Design and Methods Subjects from 10 lung transplant centres were assigned...

article

Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation

Dirk Van Raemdonck, Matthew G. Hartwig, Marshall I. Hertz, R. Duane Davis, more

The Journal of Heart and Lung Transplantation > 2017 > 36 > 10 > 1121-1136

article

Use of a novel pulmonary artery cannula to provide extracorporeal membrane oxygenation as a bridge to lung transplantation

Enrique Diaz-Guzman, Nirmal S. Sharma, Keith Wille, Charles W. Hoopes

The Journal of Heart and Lung Transplantation > 2016 > 35 > 8 > 1051-1053

article

The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia

Joshua M. Diamond, Mary K. Porteous, L. Jackson Roberts, Nancy Wickersham, more

The Journal of Heart and Lung Transplantation > 2016 > 35 > 4 > 500-507

Donor smoking history and higher fraction of inspired oxygen (Fio₂) at reperfusion are associated with primary graft dysfunction (PGD) after lung transplantation. We hypothesized that oxidative injury biomarkers would be elevated in PGD, with higher levels associated with donor exposure to cigarette smoke and recipient hyperoxia at reperfusion.We performed a nested case-control study of 72 lung transplant...

article

Pulmonary Endarterectomy for Pulmonary Hypertension From Septic Emboli

William Crosland, Mustafa Ahmed, Julian Booker, Keith Wille, more

The Annals of Thoracic Surgery > 2015 > 99 > 5 > 1814-1816

Pulmonary endarterectomy (PEA) can significantly increase long-term survival in patients with chronic thromboembolic pulmonary hypertension; however, the role of PEA for chronic thromboembolic pulmonary hypertension due to pulmonary valve endocarditis is controversial. A critically ill 61-year-old man with intractable right ventricular heart failure was found to have chronic thromboembolic pulmonary...

article

ASSESSING CONTINUOUS RENAL REPLACEMENT THERAPY AS RESCUE THERAPY FOR DIURETIC RESISTANT CARDIORENAL SYNDROME 1

Kurt Prins, Keith Wille, Ashita Tolwani

Journal of the American College of Cardiology > 2014 > 63 > 12(S) > A917

article

Management of Complications in Renal Replacement Therapy

Roman Shingarev, Keith Wille, Ashita Tolwani

Seminars in Dialysis > 24 > 2 > 164 - 168

Renal replacement therapies (RRTs) are frequently employed for treatment of patients suffering from acute kidney injury in the intensive care unit (ICU). Multiple modalities of RRT are currently available. These include intermittent hemodialysis, continuous renal replacement therapies, and hybrid therapies, such as sustained low‐efficiency dialysis. Because of the high complexity of ICU patients,...

article

177 Solute Clearance in CRRT: Comparing Measured Effluent Volume to Actual Delivered Dose

William Lyndon, Keith Wille, Ashita Tolwani

American Journal of Kidney Diseases > 2011 > 57 > 4 > B61

article

Construct validity of the definition of primary graft dysfunction after lung transplantation

Jason D. Christie, Scarlett Bellamy, Lorraine B. Ware, David Lederer, more

Journal of Heart and Lung Transplantation > 2010 > 29 > 11 > 1231-1239

This study tested the discriminant validity of International Society for Heart and Lung Transplantation (ISHLT) primary graft dysfunction (PGD) grades with lung injury biomarker profiles and survival.The study samples consisted of a multicenter prospective cohort study for the biomarker analysis and a cohort study of 450 patients for the mortality analyses. PGD was defined according to ISHLT consensus...

article

Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates

Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, more

Gastroenterology > 2008 > 135 > 4 > 1168-1175

Background & Aims: Hepatopulmonary syndrome (HPS) affects 10%–30% of patients with cirrhosis and portal hypertension, but the impact on functional status, quality of life, and survival is poorly defined. We assessed the impact of HPS in patients evaluated for liver transplantation. Methods: We performed a prospective multicenter cohort study of patients being evaluated for liver transplantation...

article

Multi-organ Transplantation: Is There a Protective Effect Against Acute and Chronic Rejection?

Laura J. Pinderski, James K. Kirklin, David McGiffin, Robert Brown, more

Journal of Heart and Lung Transplantation > 2005 > 24 > 11 > 1828-1833

Heart–lung transplantation (Tx) is known to offer a protective effect against acute cardiac rejection. This study was undertaken to evaluate acute and chronic heart and/or lung rejection in the setting of multiple-transplanted organs from the same donor compared with single-organ transplantation. Acute (treated rejection episodes of heart or lungs) and chronic (allograft vasculopathy in hearts...

Filter options

Publication date

Last 3 years (2)

Close

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

From:

To:
Set your own date range

Keywords

Data set

Elsevier (9)
Wiley (4)

Journal

The Journal of Heart and Lung Transplantation (3)
Journal of Heart and Lung Transplantation (2)
American Journal of Kidney Diseases (1)
Artificial Organs (1)
Clinical Transplantation (1)
Gastroenterology (1)
Journal of the American College of Cardiology (1)
Seminars in Dialysis (1)
The Annals of Thoracic Surgery (1)
Transfusion Medicine (1)
more

INFONA - science communication portal

Search results for: Keith Wille

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options